Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Orphan drug designation granted for non-radiolabeled TM-601

Jan. 8, 2008

Access acquires Somanta and adds four new anticancer compounds to pipeline

Jan. 8, 2008

Recent patents report novel anticancer agents

Jan. 8, 2008

MethylGene files IND application with the FDA for c-MET inhibitor MGCD-265

Jan. 7, 2008

Infinity and MedImmune initiate phase Ib clinical trial of IPI-504 with Taxotere

Jan. 7, 2008

EMEA agrees with Spectrum's clinical development plan for phase III trials of EOquin

Jan. 7, 2008

Kosan initiates TIME-1 phase III clinical trial of tanespimycin for multiple myeloma

Jan. 7, 2008

New oncolytic drugs imparted in recent patents

Jan. 7, 2008

FDA accepts IND application for EntreMed's Aurora kinase/angiogenesis inhibitor

Jan. 7, 2008

New phase I/II trial for ispinesib monotherapy in metastatic breast cancer begins

Jan. 4, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...